Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 7/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 1/20 | 0.79 |
| ▸ | MMP3 | P08254 | 1/20 | 0.79 |
| ▸ | MMP9 | P14780 | 1/20 | 0.79 |
| ▸ | MMP12 | P39900 | 1/20 | 0.79 |
| ▸ | MMP13 | P45452 | 1/20 | 0.79 |
| ▸ | KDM1A | O60341 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | BACE1 | P56817 | 1/20 | 0.62 |
| ▸ | APP | P05067 | 1/20 | 0.61 |
| ▸ | XDH | P47989 | 1/20 | 0.54 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Calceolarioside B SCHEMBL17173771 | 1.00 | PRKCA (1.00) | PRKCACYP19A1MMP2MMP3MMP9 | |
| Calceolarioside B SCHEMBL30913582 | 1.00 | PRKCA (1.00) | PRKCACYP19A1MMP2MMP3MMP9 | |
| Calceolarioside B SCHEMBL27983548 | 1.00 | PRKCA (1.00) | PRKCACYP19A1MMP2MMP3MMP9 | |
| SCHEMBL17173773 | 0.93 | PRKCA (0.86) | PRKCACYP19A1MMP2MMP3MMP9 | |
| Plantainoside D SCHEMBL23512286 | 0.91 | PRKCA (1.00) | PRKCACYP19A1MMP2MMP3MMP9 | |
| Plantainoside D SCHEMBL31060761 | 0.91 | PRKCA (1.00) | PRKCACYP19A1MMP2MMP3MMP9 | |
| SCHEMBL16277000 | 0.90 | PRKCA (0.82) | PRKCACYP19A1MMP2MMP3MMP9 | |
| SCHEMBL17177798 | 0.89 | PRKCA (0.79) | PRKCACYP19A1MMP2MMP3MMP9 | |
| Isoacteoside SCHEMBL16689428 | 0.88 | MMP2 (1.00) | PRKCACYP19A1MMP2MMP3MMP9 | |
| Isoacteoside SCHEMBL19429735 | 0.88 | MMP2 (1.00) | PRKCACYP19A1MMP2MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4606437-A1 | COSMETIC COMPOSITIONS TO INHIBIT THE ACTIVITY OF KLF4, TO REDUCE SKIN, HAIR, MUCOUS MEMBRANES AGING | LABORATOIRE NATIVE (FR) | 2025-08-27 | — | — | EP | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| CN-113491703-B | Application of phenylethanoid glycosides compounds and composition thereof in preparation of medicines for preventing and treating new coronavirus infection | 中国科学院上海药物研究所 | 2023-10-31 | — | — | CN | claimed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-4606437-A1 | COSMETIC COMPOSITIONS TO INHIBIT THE ACTIVITY OF KLF4, TO REDUCE SKIN, HAIR, MUCOUS MEMBRANES AGING | LABORATOIRE NATIVE (FR) | 2025-08-27 | — | — | EP | disclosed |
| US-20250250647-A1 | STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2025-08-07 | — | — | US | disclosed |
| CN-119523995-A | New application of akebia stem phenethyl alcohol glycoside B in preparation of MMP12 inhibitor | 上海中医药大学 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| CN-118325868-A | Alpha-L-rhamnosidase EsRha, product thereof and method for producing pharmaceutically active ingredient | 北京理工大学 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024007532-A1 | METHOD FOR DETERMINING DISSOLUTION RATES OF EIGHT REPRESENTATIVE COMPONENTS IN DAOCHI PILLS | 河北省药品医疗器械检验研究院(河北省化妆品检验研究中心) | 2024-01-11 | — | — | WO | disclosed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | disclosed |
| CN-113491703-B | Application of phenylethanoid glycosides compounds and composition thereof in preparation of medicines for preventing and treating new coronavirus infection | 中国科学院上海药物研究所 | 2023-10-31 | — | — | CN | disclosed |
| US-20230046151-A1 | SYSTEM FOR PROVIDING CUSTOMIZED COSMETICS | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| EP-4123553-A1 | SYSTEM FOR PROVIDING CUSTOMIZED COSMETICS | LG Household & Health Care Ltd. (KR) | 2023-01-25 | — | — | EP | disclosed |
| CN-115505014-A | Callicarpa nudiflora extract, preparation method and application thereof | 江中药业股份有限公司 | 2022-12-23 | — | — | CN | disclosed |
| US-20220273748-A1 | PLANT FERMENT AND WEIGHT LOSS METHOD FOR USING THE SAME | TCI CO., LTD. (TW) | 2022-09-01 | — | — | US | disclosed |
| CN-114787851-A | Customized cosmetic providing system | 株式会社LG生活健康 | 2022-07-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273748-A1 | PLANT FERMENT AND WEIGHT LOSS METHOD FOR USING THE SAME | FABP6, MGAM, FUCA1 | PRKCA 2176/4885CYP19A1 4203/4885MMP2 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.